Literature DB >> 23448800

The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan.

Takahiro Higashi1, Fumiaki Nakamura, Akiko Shibata, Yoshiko Emori, Hiroshi Nishimoto.   

Abstract

Monitoring the current status of cancer care is essential for effective cancer control and high-quality cancer care. To address the information needs of patients and physicians in Japan, hospital-based cancer registries are operated in 397 hospitals designated as cancer care hospitals by the national government. These hospitals collect information on all cancer cases encountered in each hospital according to precisely defined coding rules. The Center for Cancer Control and Information Services at the National Cancer Center supports the management of the hospital-based cancer registry by providing training for tumor registrars and by developing and maintaining the standard software and continuing communication, which includes mailing lists, a customizable web site and site visits. Data from the cancer care hospitals are submitted annually to the Center, compiled, and distributed as the National Cancer Statistics Report. The report reveals the national profiles of patient characteristics, route to discovery, stage distribution, and first-course treatments of the five major cancers in Japan. A system designed to follow up on patient survival will soon be established. Findings from the analyses will reveal characteristics of designated cancer care hospitals nationwide and will show how characteristics of patients with cancer in Japan differ from those of patients with cancer in other countries. The database will provide an infrastructure for future clinical and health services research and will support quality measurement and improvement of cancer care. Researchers and policy-makers in Japan are encouraged to take advantage of this powerful tool to enhance cancer control and their clinical practice.

Entities:  

Keywords:  cancer registry; data infrastructure; national database; quality of care

Mesh:

Year:  2013        PMID: 23448800     DOI: 10.1093/jjco/hyt013

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  24 in total

1.  The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.

Authors:  Yoichiro Tsukada; Takahiro Higashi; Hideaki Shimada; Yoshinori Kikuchi; Atsuro Terahara
Journal:  Int J Clin Oncol       Date:  2017-08-09       Impact factor: 3.402

2.  Methods and implementation of a Hospital-Based Cancer Registry in a major city in a low-to middle-income country: the case of Cali, Colombia.

Authors:  Luis G Parra-Lara; Diana M Mendoza-Urbano; Ángela R Zambrano; Andrea Valencia-Orozco; Juan C Bravo-Ocaña; Luis E Bravo-Ocaña; Fernando Rosso
Journal:  Cancer Causes Control       Date:  2022-01-11       Impact factor: 2.506

3.  Increased risk of metastasis in patients with incidental use of renin-angiotensin system inhibitors: a retrospective analysis for multiple types of cancer based on electronic medical records.

Authors:  Akie Hirata; Shin Ishikane; Fumi Takahashi-Yanaga; Masaki Arioka; Tasuku Okui; Chinatsu Nojiri; Toshiyuki Sasaguri; Naoki Nakashima
Journal:  Hypertens Res       Date:  2022-09-28       Impact factor: 5.528

4.  The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan.

Authors:  Shun Yamamoto; Naoki Sakakibara; Hidekazu Hirano; Chigusa Morizane; Yoshitaka Honma; Susumu Hijioka; Takuji Okusaka; Takahiro Higashi; Akira Kawai
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

5.  A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research.

Authors:  Rémy Choquet; Meriem Maaroufi; Albane de Carrara; Claude Messiaen; Emmanuel Luigi; Paul Landais
Journal:  J Am Med Inform Assoc       Date:  2014-07-18       Impact factor: 4.497

6.  Treatment selection for esophageal cancer: evaluation from a nationwide database.

Authors:  Yasuo Hamamoto; Naoki Sakakibara; Fumio Nagashima; Yuko Kitagawa; Takahiro Higashi
Journal:  Esophagus       Date:  2018-02-20       Impact factor: 4.230

7.  Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009 - 2015.

Authors:  Tomonobu Koizumi; Kengo Otsuki; Yuriko Tanaka; Shintaro Kanda
Journal:  BMC Endocr Disord       Date:  2022-04-20       Impact factor: 2.763

Review 8.  Effect of practice management softwares among physicians of developing countries with special reference to Indian scenario by Mixed Method Technique.

Authors:  Sanjeev Davey; Anuradha Davey
Journal:  J Family Med Prim Care       Date:  2015 Apr-Jun

Review 9.  Cancer control programs in East Asia: evidence from the international literature.

Authors:  Malcolm A Moore
Journal:  J Prev Med Public Health       Date:  2014-07-31

10.  Incidence of myelodysplastic syndrome in Japan.

Authors:  Dai Chihara; Hidemi Ito; Kota Katanoda; Akiko Shibata; Tomohiro Matsuda; Tomotaka Sobue; Keitaro Matsuo
Journal:  J Epidemiol       Date:  2014-08-02       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.